Patents by Inventor Adam Wheeler

Adam Wheeler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11384356
    Abstract: The invention provides aptamer-gene modulator conjugates, where the aptamer and the gene modulator are linked together. The invention further provides a method for cell-specific delivery of gene modulators to hard to transfect cells such as CD4+ cell.
    Type: Grant
    Filed: May 24, 2019
    Date of Patent: July 12, 2022
    Assignee: The Children's Medical Center Corporation
    Inventors: Judy Lieberman, Lee Adams Wheeler
  • Patent number: 11180762
    Abstract: Described herein are methods and compositions relating to the treatment of cancer, e.g., breast cancer, using, e.g., aptamer-siRNA chimera molecules.
    Type: Grant
    Filed: May 10, 2019
    Date of Patent: November 23, 2021
    Assignee: CHILDREN'S MEDICAL CENTER CORPORATION
    Inventors: Judy Lieberman, Adi Gilboa-Geffen, Lee Adam Wheeler
  • Patent number: 10711597
    Abstract: An embodiment of a method of communicating between a surface processing unit and an energy industry tool includes: receiving a power signal from a power source at an integrated interface device of a communication and processing system, the communication and processing system located between a surface processing unit and an energy industry tool, the interface device including a processor and a variable output power supply; receiving a communication at the processor from a surface processing unit; transmitting a control signal from the processor to the variable output power supply, the control signal including a series of pulses having a duty cycle that is varied to cause the power supply to generate a modulated direct current (DC) output signal having at least one of a frequency and an amplitude that is modulated according to a communication protocol to represent the communication; and transmitting the modulated output signal to a tool.
    Type: Grant
    Filed: May 19, 2016
    Date of Patent: July 14, 2020
    Assignee: BAKER HUGHES, A GE COMPANY, LLC
    Inventors: Adam Wheeler, Stephen Coulston, Paul Halstead
  • Publication number: 20190359987
    Abstract: The invention provides aptamer-gene modulator conjugates, where the aptamer and the gene modulator are linked together. The invention further provides a method for cell-specific delivery of gene modulators to hard to transfect cells such as CD4+ cell.
    Type: Application
    Filed: May 24, 2019
    Publication date: November 28, 2019
    Applicant: The Children's Medical Center Corporation
    Inventors: Judy Lieberman, Lee Adams Wheeler
  • Publication number: 20190309297
    Abstract: Described herein are methods and compositions relating to the treatment of cancer, e.g., breast cancer, using, e.g., aptamer-siRNA chimera molecules.
    Type: Application
    Filed: May 10, 2019
    Publication date: October 10, 2019
    Applicant: CHILDREN'S MEDICAL CENTER CORPORATION
    Inventors: Judy LIEBERMAN, Adi GILBOA-GEFFEN, Lee Adam WHEELER
  • Patent number: 10385343
    Abstract: Described herein are methods and compositions relating to the treatment of cancer, e.g., breast cancer, using, e.g., aptamer-siRNA chimera molecules.
    Type: Grant
    Filed: August 28, 2015
    Date of Patent: August 20, 2019
    Assignee: CHILDREN'S MEDICAL CENTER CORPORATION
    Inventors: Judy Lieberman, Adi Gilboa-Geffen, Lee Adam Wheeler
  • Patent number: 10378016
    Abstract: The invention provides aptamer-gene modulator conjugates, where the aptamer and the gene modulator are linked together. The invention further provides a method for cell-specific delivery of gene modulators to hard to transfect cells such as CD4+ cell.
    Type: Grant
    Filed: December 6, 2011
    Date of Patent: August 13, 2019
    Assignee: Children's Medical Center Corporation
    Inventors: Judy Lieberman, Lee Adam Wheeler
  • Publication number: 20170275629
    Abstract: Described herein are methods and compositions relating to the treatment of cancer, e.g., breast cancer, using, e.g., aptamer-siRNA chimera molecules.
    Type: Application
    Filed: August 28, 2015
    Publication date: September 28, 2017
    Applicant: CHILDREN'S MEDICAL CENTER CORPORATION
    Inventors: Judy LIEBERMAN, Adi GILBOA-GEFFEN, Lee Adam WHEELER
  • Publication number: 20160369622
    Abstract: An embodiment of a method of communicating between a surface processing unit and an energy industry tool includes: receiving a power signal from a power source at an integrated interface device of a communication and processing system, the communication and processing system located between a surface processing unit and an energy industry tool, the interface device including a processor and a variable output power supply; receiving a communication at the processor from a surface processing unit; transmitting a control signal from the processor to the variable output power supply, the control signal including a series of pulses having a duty cycle that is varied to cause the power supply to generate a modulated direct current (DC) output signal having at least one of a frequency and an amplitude that is modulated according to a communication protocol to represent the communication; and transmitting the modulated output signal to a tool.
    Type: Application
    Filed: May 19, 2016
    Publication date: December 22, 2016
    Applicant: Baker Hughes Incorporated
    Inventors: Adam Wheeler, Stephen Coulston, Paul Halstead
  • Publication number: 20130338215
    Abstract: The invention provides aptamer-gene modulator conjugates, where the aptamer and the gene modulator are linked together. The invention further provides a method for cell-specific delivery of gene modulators to hard to transfect cells such as CD4+ cell.
    Type: Application
    Filed: December 6, 2011
    Publication date: December 19, 2013
    Inventors: Judy Lieberman, Lee Adam Wheeler